A study to evaluate the effect of wood creosote on intestinal flora

Not Applicable

• Conditions: Healthy adult

• Registration Number: JPRN-UMIN000026926
• Lead Sponsor: Taiko Pharmaceutical Co., Ltd.

Brief Summary

o decrease of the number of intestinal bacteria was confirmed when regular-dose wood creosote was administered. Based upon this result, it is concluded that intestinal bacteria are not killed by the administration of regular-dose wood creosote.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-04-28
• Study Completion: 2017-06-15
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Not provided

Exclusion Criteria

1.Subjects who have a disease under treatment 2.Subjects who have diarrhea with fever, bloody stool or continued mucus stool 3.Pregnant and lactating female, or subjects who are judged as pregnant 4.Subjects who have hypersensitivity or idiosyncrasy to drugs, in particular wood creosote, or those with a history of that 5.Subjects with constipation or diarrhea 6.Subjects who have more drinking habits than the appropriate range and excessive smoking habits 7.Subjects who used or took a medicine within one week before the first day of the study or those who need to use or take a medicine 8.Subjects who take foods for specified health uses , foods with function claims and foods with nutrient function claims (supplements in capsule form and others), excluding those who can stop taking those foods after informed consent) 9.Shift workers during the night 10.Subjects who cannot regularly consume three meals in the morning, noon, and evening, every day 11.Subjects who are planning to travel both domestically and abroad for one week before the first day of the study or during the study period 12.Subjects who cannot participate in the screening test and the study period (7 days), or who cannot visit on the prescribed date 13.Subjects who are unable to fill in their daily diaries during the prescribed period 14.Subjects who donated more than 200 mL of blood within one month before the first day of the study or subjects who have the schedule during the study period 15.Subjects who participated in other clinical trials within 12 weeks before the first day of the study and received medication 16.Subjects who are judged as ineligible to participate in the study for other reasons by the principal investigator

Study & Design

• Study Type: Interventional
• Study Design: Not specified